Member Exclusive

Guadecitabine shown to be safe in metastatic colorectal cancer patients

In a small Phase I study conducted at Johns Hopkins School of Medicine (MD, USA), guadecitabine has been shown to be safe in combination with irinotecan for treatment of metastatic colorectal cancer.

Go to the profile of Georgia Patey
Apr 20, 2016
0
0

Please sign in or register for FREE

Register to EpigenomicsNet – the epigenetics and epigenomics network

EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.